<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31740840</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing.</ArticleTitle><Pagination><StartPage>1478</StartPage><EndPage>1481</EndPage><MedlinePgn>1478-1481</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41587-019-0293-x</ELocationID><Abstract><AbstractText>Expansions of short tandem repeats are genetic variants that have been implicated in several neuropsychiatric and other disorders, but their assessment remains challenging with current polymerase-based methods<sup>1-4</sup>. Here we introduce a CRISPR-Cas-based enrichment strategy for nanopore sequencing combined with an algorithm for raw signal analysis. Our method, termed STRique for short tandem repeat identification, quantification and evaluation, integrates conventional sequence mapping of nanopore reads with raw signal alignment for the localization of repeat boundaries and a hidden Markov model-based repeat counting mechanism. We demonstrate the precise quantification of repeat numbers in conjunction with the determination of CpG methylation states in the repeat expansion and in adjacent regions at the single-molecule level without amplification. Our method enables the study of previously inaccessible genomic regions and their epigenetic marks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Giesselmann</LastName><ForeName>Pay</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1227-897X</Identifier><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Br&#xe4;ndl</LastName><ForeName>Bj&#xf6;rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Schleswig-Holstein Campus Kiel, Zentrum f&#xfc;r Integrative Psychiatrie gGmbH, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raimondeau</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Oxford Nanopore Technologies, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Oxford Nanopore Technologies, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohrandt</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3661-1183</Identifier><AffiliationInfo><Affiliation>Kiel University of Applied Sciences, Institute for Communications Technologies and Embedded Systems, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Rashmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Schleswig-Holstein Campus Kiel, Zentrum f&#xfc;r Integrative Psychiatrie gGmbH, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kretzmer</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assum</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galonska</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebert</LastName><ForeName>Reiner</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammerpohl</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institute for Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heron</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oxford Nanopore Technologies, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Susanne A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ludwig-Maximilians-Universit&#xe4;t, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladewig</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HITBR Hector Institute for Translational Brain Research gGmbH, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Research Center, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Reconstructive Neurobiology, University of Bonn School of Medicine &amp; University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HITBR Hector Institute for Translational Brain Research gGmbH, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Research Center, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Reconstructive Neurobiology, University of Bonn School of Medicine &amp; University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuldt</LastName><ForeName>Bernhard M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Schleswig-Holstein Campus Kiel, Zentrum f&#xfc;r Integrative Psychiatrie gGmbH, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>James E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Oxford Nanopore Technologies, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8646-7469</Identifier><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Franz-Josef</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0001-9478-8430</Identifier><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany. franz-josef.mueller@uksh.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Schleswig-Holstein Campus Kiel, Zentrum f&#xfc;r Integrative Psychiatrie gGmbH, Kiel, Germany. franz-josef.mueller@uksh.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Genet. 2020 Feb;21(2):67</RefSource><PMID Version="1">31811281</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018895" MajorTopicYN="N">Microsatellite Repeats</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081414" MajorTopicYN="N">Nanopore Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058608" MajorTopicYN="N">Nanopores</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31740840</ArticleId><ArticleId IdType="doi">10.1038/s41587-019-0293-x</ArticleId><ArticleId IdType="pii">10.1038/s41587-019-0293-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245&#x2013;256 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21944779</ArticleId><ArticleId IdType="pmc">3200438</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook, A. et al. The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 310&#x2013;316 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30907153</ArticleId></ArticleIdList></Reference><Reference><Citation>Klepek, H., Goutman, S. A., Quick, A., Kolb, S. J. &amp; Roggenbuck, J. Variable reporting of C9orf72 and a high rate of uncertain results in ALS genetic testing. Neurol. Genet. 5, e301 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30697590</ArticleId><ArticleId IdType="pmc">6340336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatchel, J. R. &amp; Zoghbi, H. Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743&#x2013;755 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16205714</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson, H. Repeat expansion diseases. Handb. Clin. Neurol. 147, 105&#x2013;123 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29325606</ArticleId><ArticleId IdType="pmc">6485936</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkerk, A. J. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905&#x2013;914 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1710175</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk, M. et al. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol. 12, 978&#x2013;988 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi, Z. et al. Hypermethylation of the CpG island near the G<sub>4</sub>C<sub>2</sub> repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet. 92, 981&#x2013;989 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23731538</ArticleId><ArticleId IdType="pmc">3675239</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ, J. et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 129, 39&#x2013;52 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Deamer, D., Akeson, M. &amp; Branton, D. Three decades of nanopore sequencing. Nat. Biotechnol. 34, 518&#x2013;524 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27153285</ArticleId><ArticleId IdType="pmc">6733523</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, C. G. &amp; Clarke, J. Nanopore development at Oxford Nanopore. Nat. Biotechnol. 34, 810&#x2013;811 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27504770</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain, M. et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat. Biotechnol. 36, 338&#x2013;345 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29431738</ArticleId><ArticleId IdType="pmc">5889714</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, J. T. et al. Detecting DNA cytosine methylation using nanopore sequencing. Nat. Methods 14, 407&#x2013;410 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28218898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rand, A. C. et al. Mapping DNA methylation with high-throughput nanopore sequencing. Nat. Methods 14, 411&#x2013;413 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28218897</ArticleId><ArticleId IdType="pmc">5704956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska, S. et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345, 1192&#x2013;1194 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25103406</ArticleId><ArticleId IdType="pmc">4944841</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashnow, H. et al. STRetch: detecting and discovering pathogenic short tandem repeat expansions. Genome Biol. 19, 121 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30129428</ArticleId><ArticleId IdType="pmc">6102892</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Q., Zhang, P., Wang, D., Gu, W. &amp; Wang, K. Interrogating the &#x2018;unsequenceable&#x2019; genomic trinucleotide repeat disorders by long-read sequencing. Genome Med. 9, 65 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28720120</ArticleId><ArticleId IdType="pmc">5514472</ArticleId></ArticleIdList></Reference><Reference><Citation>Wick, R.R., Judd, L.M. &amp; Holt, K.E. Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol. 20, 129 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31234903</ArticleId><ArticleId IdType="pmc">6591954</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 3, 321 (2018).</Citation></Reference><Reference><Citation>Schreiber, J. &amp; Karplus, K. Analysis of nanopore data using hidden Markov models. Bioinformatics 31, 1897&#x2013;1903 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25649617</ArticleId><ArticleId IdType="pmc">4553831</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke, J. G. et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron 88, 892&#x2013;901 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26637796</ArticleId><ArticleId IdType="pmc">4672384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR&#x2013;Cas system. Cell 163, 759&#x2013;771 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26422227</ArticleId><ArticleId IdType="pmc">26422227</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland, M. J. et al. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome. Brain 140, 582&#x2013;598 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28137726</ArticleId><ArticleId IdType="pmc">5837342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839&#x2013;843 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23934178</ArticleId><ArticleId IdType="pmc">3782611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornstra, L. K., Nelson, D. L., Warren, S. T. &amp; Yang, T. P. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum. Mol. Genet. 2, 1659&#x2013;1665 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8268919</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi, Z. et al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 129, 715&#x2013;727 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25716178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons, J. I., Kerr, G. R. &amp; Mueller, P. W. Fragile X syndrome: scientific background and screening technologies. J. Mol. Diagn. 17, 463&#x2013;471 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26162330</ArticleId><ArticleId IdType="pmc">4620545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen, R. S., Gartler, S. M., Scott, C. R., Chen, S.-H. &amp; Laird, C. M. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum. Mol. Genet. 1, 571&#x2013;578 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1301165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrieli, T. et al. Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH). Nucleic Acids Res. 46, e87 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29788371</ArticleId><ArticleId IdType="pmc">6101500</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinert, K. et al. The SeqAn C++ template library for efficient sequence analysis: a resource for programmers. J. Biotechnol. 261, 157&#x2013;168 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28888961</ArticleId></ArticleIdList></Reference><Reference><Citation>Giesselmann, P., Hetzel, S., M&#xfc;ller, F.-J., Meissner, A. &amp; Kretzmer, H. Nanopype: a modular and scalable nanopore data processing pipeline. Bioinformatics 26, 2204 (2019).</Citation></Reference><Reference><Citation>Rohrandt, C. et al. Nanopore SimulatION&#x2013;a raw data simulator for nanopore sequencing. in 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 1&#x2013;8 (IEEE, 2019).</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2019).</Citation></Reference><Reference><Citation>Gu, Z., Eils, R. &amp; Schlesner, M. Complex heat maps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847&#x2013;2849 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Z., Gu, L., Eils, R., Schlesner, M. &amp; Brors, B. Circlize implements and enhances circular visualization in R. Bioinformatics 30, 2811&#x2013;2812 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24930139</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook, J. &amp; Maniatis, T. Molecular Cloning (Cold Spring Harbor Laboratory Press, 1989).</Citation></Reference><Reference><Citation>Labun, K., Montague, T. G., Gagnon, J. A., Thyme, S. B. &amp; Valen, E. CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res. 44, W272&#x2013;W276 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27185894</ArticleId><ArticleId IdType="pmc">4987937</ArticleId></ArticleIdList></Reference><Reference><Citation>Montague, T. G., Cruz, J. M., Gagnon, J. A., Church, G. M. &amp; Valen, E. CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 42, W401&#x2013;W407 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24861617</ArticleId><ArticleId IdType="pmc">4086086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J. S. et al. CRISPR&#x2013;Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360, 436&#x2013;439 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29449511</ArticleId><ArticleId IdType="pmc">6628903</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok, Y. K. et al. Validation of a robust PCR-based assay for quantifying fragile X CGG repeats. Clin. Chim. Acta 456, 137&#x2013;143 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26947966</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424&#x2013;429 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21478862</ArticleId><ArticleId IdType="pmc">3084903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens, J. et al. APP processing in human pluripotent stem cell-derived neurons is resistant to NSAID-based &#x3b3;-secretase modulation. Stem Cell Rep. 1, 491&#x2013;498 (2013).</Citation></Reference><Reference><Citation>Zhou, Y., Kumari, D., Sciascia, N. &amp; Usdin, K. CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons. Mol. Autism 7, 165 (2016).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>